https://www.selleckchem.com/pr....oducts/tocilizumab.h
This is the first study evaluating FM% in COVID-19 patient. We underlined obese characteristic with likely poorly prognosis and an important misclassification of obesity. A not negligible number of patients with normal BMI could actually have an excess of adipose tissue and therefore have an unfavorable outcome such as an obese. Is fundamental personalized patients nutrition basing on disease phases. This is the first study evaluating FM% in COVID-19 patient. We underlined obese characteristic with likely poorly prognosis and an imp
Like
Comment
Share
